| Company Name: |
Sigma-Aldrich |
| Tel: |
021-61415566 800-8193336 |
| Email: |
orderCN@merckgroup.com |
| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
p38 MAP Kinase Inhibitor III manufacturers
|
| | p38 MAP Kinase Inhibitor III Basic information |
| Product Name: | p38 MAP Kinase Inhibitor III | | Synonyms: | p38 MAP Kinase Inhibitor III - CAS 581098-48-8 - Calbiochem;(S)-p38 MAPK Inhibitor III;2-Pyridinamine, 4-[5-(4-fluorophenyl)-2-(methylthio)-1H-imidazol-4-yl]-N-[(1S)-1-phenylethyl]-;(S)-p38 MAP Kinase Inhibitor III;(S)-p-38 MAPK Inhibitor III,(S) p38 MAPK Inhibitor III,(S)p38 MAPK Inhibitor III;4-[5-(4-fluorophenyl)-2-(methylthio)-1H-imidazol-4-yl]-N-[(1S)-1-phenylethyl]-2-pyridinamine | | CAS: | 581098-48-8 | | MF: | C23H21FN4S | | MW: | 404.5 | | EINECS: | | | Product Categories: | | | Mol File: | 581098-48-8.mol |  |
| | p38 MAP Kinase Inhibitor III Chemical Properties |
| Melting point | 117-119 °C | | Boiling point | 589.4±60.0 °C(Predicted) | | density | 1.30±0.1 g/cm3(Predicted) | | storage temp. | +2C to +8C | | solubility | DMF: 20 mg/mL; DMSO: 12 mg/mL; Ethanol: 30 mg/mL; Ethanol:PBS (pH 7.2)(1:2): 0.33 mg/mL | | form | Yellow solid | | pka | 9.07±0.10(Predicted) | | color | White to off-white | | InChI | 1S/C23H21FN4S/c1-15(16-6-4-3-5-7-16)26-20-14-18(12-13-25-20)22-21(27-23(28-22)29-2)17-8-10-19(24)11-9-17/h3-15H,1-2H3,(H,25,26)(H,27,28) | | InChIKey | VXPWQNBKEIVYIS-UHFFFAOYSA-N | | SMILES | Fc1ccc(cc1)c2[nH]c(nc2c3cc(ncc3)NC(C)c4ccccc4)SC |
| WGK Germany | WGK 1 | | Storage Class | 11 - Combustible Solids |
| | p38 MAP Kinase Inhibitor III Usage And Synthesis |
| Description | (S)-p38 MAPK inhibitor III is a methylsulfanylimidazole that inhibits p38 MAP kinase (IC50 = 0.90 μM in vitro). It is cell-permeable, potently blocking the release of TNF-α and IL-1β from human peripheral blood mononuclear cells (IC50s = 0.37 and 0.044 μM, respectively). | | Uses | p38 MAP Kinase Inhibitor III (compound 7h) is a p38 MAPK inhibitor with an 50 of 0.9 μM. p38 MAP Kinase Inhibitor III also inhibits IL-1β and TNF-α release with 50 values of 0.37 μM and 0.044 μM, respectively[1]. | | General Description | A cell-permeable methylsulfanylimidazole compound that acts as a potent, selective, reversible, and ATP-competitive p38 MAP kinase inhibitor (IC50 = 0.38 μM for p38α). Shown to effectively suppresses LPS-induced cytokine release both in vitro (IC50 = 0.16 and 0.039 μM for TNF-α and IL-1β release, respectively, in human PBMC) and in vivo (ED50 = 1.33 mg/kg for TNF-α release in mouse). When compared with SB 203580 (Cat. No. 559389 and 559398), it exhibits reduced inhibitory activity against cytochrome P450-2D6 isoform and, therefore, is better suited for in vivo use. A 10 mM (1 mg/247 μl) solution of p38 MAP Kinase Inhibitor III (Cat. No. 506148) in DMSO is also available. | | Biochem/physiol Actions | Cell permeable: yes | | IC 50 | p38 MAP kinase: 0.9 μM (IC50) | | References | [1] Stefan A Laufer, et al. Novel substituted pyridinyl imidazoles as potent anticytokine agents with low activity against hepatic cytochrome P450 enzymes. J Med Chem. 2003 Jul 17;46(15):3230-44. DOI:10.1021/jm030766k |
| | p38 MAP Kinase Inhibitor III Preparation Products And Raw materials |
|